Why is Ipca Labs falling/rising?

As of 17-Jul, Ipca Laboratories Ltd's stock price is currently at 1,475.75, reflecting an increase of 13.1, or 0.9%. The stock has outperformed its sector today by 0.48%, and it is trading higher than its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. Over the past week, the stock has shown a return of +1.71%, significantly outperforming the Sensex, which has declined by -1.12%. Additionally, the company has reported positive results for the last four consecutive quarters, with a notable growth in PAT of 119.56% over the latest six months and a high ROCE of 17.10%. The stock's strong performance over the past year, generating a return of 20.85%, further underscores its resilience compared to the broader market. In the broader market context, while Ipca Laboratories has demonstrated a solid short-term performance, the Sensex has shown a slight decline, indicating that the stock is currently gaining traction against a backdrop of market weakness. However, there is a concern regarding falling investor participation, as evidenced by a 45.25% drop in delivery volume compared to the 5-day average. Despite this, the stock benefits from high institutional holdings at 46.82%, which suggests confidence from more knowledgeable investors. Overall, the combination of strong financial performance and institutional backing appears to be driving the stock's recent upward movement, even as broader market conditions remain challenging.